Status:
UNKNOWN
Customized Crosslinking: Safety and Efficacy in an Epithelium-off Accelerated-pulsated Protocol for Thin Keratoconus
Lead Sponsor:
Instituto de Oftalmología Fundación Conde de Valenciana
Conditions:
Keratoconus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to document corneal ectasia stability in patients with keratoconus diagnosis treated with personalized cross linking energy. The main questions it aims to answer are...
Eligibility Criteria
Inclusion
- Keratoconus diagnosed with corneal tomography/topography
- Thinnest point pachymetry below 400 microns
Exclusion
- Previous corneal cross linking history
- Corneal scars not allowing best corrected visual acuity of 20/100 or better
- Previous corneal hydrops history
- Psychomotor retardation history
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06159881
Start Date
March 1 2023
End Date
May 15 2024
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Oftalmología Conde de Valenciana
Mexico City, Mexico